SOUTH SAN FRANCISCO, Calif., May 05, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Earlier today, CareDx released financial results for the quarter ending March 31, 2020. Peter Maag, Chief Executive Officer; and Michael Bell, Chief Financial Officer, will host this afternoon's call
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA), with a price target of $40.00. The company's shares
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA – Research Report),
Q1 2020 CareDx Inc Earnings Call
CareDx Inc (NASDAQ:CDNA)’s stock price was down 5.5% during mid-day trading on Thursday following a weaker than expected earnings announcement. The stock traded as low as $25.04 and last traded at $
CareDx, Inc (NASDAQ:CDNA) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Greg Chodaczek - Head of Investor Relations Peter Maag
CareDx (CDNA) delivered earnings and revenue surprises of -100.00% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CareDx: 1Q Earnings Snapshot

11:08pm, Thursday, 30'th Apr 2020
SOUTH SAN FRANCISCO, Calif. (AP) _ CareDx Inc. (CDNA) on Thursday reported a loss of $5.8 million in its first quarter. On a per-share basis, the South San Francisco, California-based company said it
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE